Clearmind's CMND100 Trial Gets Hadassah Approval
Update: 2025-11-13
Description
Clearmind Medicines CMND one hundred drug receives final approval for Phase One slash Two A clinical trial at Hadassah Medical Center, marking a significant step forward in treating Alcohol Use Disorder. The multinational trial aims to assess safety, body tolerance, drug movement, and effectiveness in reducing alcohol cravings and consumption.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
